Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Echocardiographic characterisation in critical Covid19 - an observational study

Henrik Isackson, Anders Larsson, Miklos Lipcsey, View ORCID ProfileRobert Frithiof, Frank A. Flachskampf, View ORCID ProfileMichael Hultström
doi: https://doi.org/10.1101/2021.07.23.21261025
Henrik Isackson
1Department of Medical Sciences, Cardiology and Clinical Physiology, Uppsala University, Sweden
5Department of Medical Cell Biology, Integrative Physiology, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: henrik.isackson@mcb.uu.se
Anders Larsson
2Department of Medical Sciences, Clinical Chemistry, Uppsala University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Miklos Lipcsey
3Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
4Hedenstierna laboratory, CIRRUS, Anesthesiology and Intensive Care, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Frithiof
3Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Robert Frithiof
Frank A. Flachskampf
1Department of Medical Sciences, Cardiology and Clinical Physiology, Uppsala University, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Hultström
3Department of Surgical Sciences, Anaesthesiology and Intensive Care Medicine, Uppsala University, Uppsala, Sweden
5Department of Medical Cell Biology, Integrative Physiology, Uppsala University, Uppsala, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Hultström
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective We aimed to investigate the acute cardiac effects of severe SARS-CoV-2.

Methods This is an observational study generated from the first 79 patients admitted to Uppsala intensive care due to respiratory failure with SARS-CoV-2 infection. 34 underwent echocardiography of which 25 were included in the study and compared to 44 non-echo patients. Exclusion was based on absence of normofrequent sinus rhythm and mechanical respiratory support. Biomarker analysis was carried out on all patients.

Results Mortality was increased in the echo compared to non-echo group (44 % vs. 16%, p<0.05). Right sided dimensions and functional parameters were not affected. Tricuspid regurgitation velocity indicated how increased pulmonary artery pressure was associated with mortality (survivors (n=5): 2.51 ± 0.01 m/s vs. non-survivors (n=5): 3.06 ± 0.11 m/s, p<0.05). Cardiac markers and D-dimer correlated to initiation of echocardiography (hs-TnI (ng/L): echo (n=23): 133 ± 45 vs. non-echo (n=41): 81.3 ± 45, p<0.01; NTproBNP (ng/L): echo (n=25): 2959 ± 573 vs. non-echo (n=42): 1641 ± 420, p<0.001; D-dimer (mg/L): echo (n=25): 16.1 ± 3.7 vs. non-echo (n=43: 6.1 ± 1.5, p<0.01) and mortality (hs-TnI (ng/L): survivors (n=48): 59.1 ± 21 vs. non-survivors (n=17): 211 ± 105, p<0.0001; NT-proBNP (ng/L): survivors (n=47): 1310 ± 314 vs. non-survivors (n=20): 4065 ± 740, p<0.0001; D-dimer (mg/L): survivors (n=50): 7.2 ± 1.5 vs. non-survivors (n=18): 17.1 ± 4.8, p<0.01). All intervals refer to standard error of the mean. Tricuspid regurgitation velocity was correlated with troponin I (r=0.93, r2=0.74, p<0.001, n=10).

Conclusions These results suggest that there is no clear negative effect on cardiac function in critical SARS-CoV-2. There are indications that pulmonary pressure elevation carries a negative predictive outcome suggesting pulmonary disease as the driver of mortality. Cardiac biomarkers as well as D-dimer carry predictive value.

Trial registration number Patients were included in “Clinical trials NCT04316884”

Strength and limitations of this study

  • - The patient body is recruited from all patients admitted to ICU in need of mechanical respiratory support independent of background which makes it relevant to clinical practice.

  • - The echocardiographic image acquisition was carried out by hospital assigned agents on clinical indication, which makes the results applicable in a clinical setting.

  • - Since the image acquisition was carried out on a clinical indication, the results may be skewed towards the false positive if applied to all Covid19 patients.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04316884

Funding Statement

The study was funded by the SciLifeLab/KAW national Covid-19 research program project grants to MH (KAW 2020.0182 and KAW 2020.0241), and the Swedish Research Council to RF (2014-02569 and 2014-07606). HI was supported by the Swedish Society of Medical Research (SSMF).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Swedish National Ethical Review Authority EPM; 2020-01623

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data is available from the author upon reasonable request

  • List of abbreviations

    A
    atrial transmitral diastolic velocity
    ACE-2
    angiotensin converting enzyme 2
    ACEi
    angiotensin converting enzyme inhibitor
    ARB
    angiotensin receptor blocker
    Ang
    angiotensin
    BMI
    body mass index
    Covid-19
    corona virus disease 2019
    E
    early transmitral diastolic velocity
    e’
    medial tissue diastolic velocity
    EACVI
    European association of cardiovascular imaging
    ESC
    European society of cardiology
    FAC
    fractional area change
    GLS
    global longitudinal strain
    hs-TnI
    high sensitivity troponin I
    ICU
    intensive care unit
    IVC
    inferior vena cava
    IVC resp. variation
    inferior vena cava respiratory variation
    IVSD
    interventricular septum diameter
    LA
    left atrium
    LV
    left ventricle
    LVEDD
    left ventricular end diastolic diameter
    LVEF
    left ventricular ejection fraction
    LVPWD
    left ventricular posterior wall end diastolic diameter
    MV dec. time
    mitral valve deceleration time
    ns
    not significant
    NT-proBNP
    N-terminal pro brain natriuretic peptide
    PH
    pulmonary hypertension
    PAAT
    pulmonary artery acceleration time
    RA
    right atrium
    RV
    right ventricle
    RVD1
    right ventricular basal diameter
    SARS-CoV-2
    severe acute respiratory syndrome corona virus 2
    TAPSE
    tricuspid annular peak systolic excursion
    TR Vmax
    maximum tricuspid regurgitation velocity
  • Copyright 
    The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
    Back to top
    PreviousNext
    Posted September 24, 2021.
    Download PDF
    Data/Code
    Email

    Thank you for your interest in spreading the word about medRxiv.

    NOTE: Your email address is requested solely to identify you as the sender of this article.

    Enter multiple addresses on separate lines or separate them with commas.
    Echocardiographic characterisation in critical Covid19 - an observational study
    (Your Name) has forwarded a page to you from medRxiv
    (Your Name) thought you would like to see this page from the medRxiv website.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Share
    Echocardiographic characterisation in critical Covid19 - an observational study
    Henrik Isackson, Anders Larsson, Miklos Lipcsey, Robert Frithiof, Frank A. Flachskampf, Michael Hultström
    medRxiv 2021.07.23.21261025; doi: https://doi.org/10.1101/2021.07.23.21261025
    Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
    Citation Tools
    Echocardiographic characterisation in critical Covid19 - an observational study
    Henrik Isackson, Anders Larsson, Miklos Lipcsey, Robert Frithiof, Frank A. Flachskampf, Michael Hultström
    medRxiv 2021.07.23.21261025; doi: https://doi.org/10.1101/2021.07.23.21261025

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Subject Area

    • Cardiovascular Medicine
    Subject Areas
    All Articles
    • Addiction Medicine (163)
    • Allergy and Immunology (416)
    • Anesthesia (92)
    • Cardiovascular Medicine (865)
    • Dentistry and Oral Medicine (159)
    • Dermatology (98)
    • Emergency Medicine (251)
    • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (397)
    • Epidemiology (8587)
    • Forensic Medicine (4)
    • Gastroenterology (390)
    • Genetic and Genomic Medicine (1766)
    • Geriatric Medicine (168)
    • Health Economics (373)
    • Health Informatics (1250)
    • Health Policy (624)
    • Health Systems and Quality Improvement (470)
    • Hematology (197)
    • HIV/AIDS (379)
    • Infectious Diseases (except HIV/AIDS) (10333)
    • Intensive Care and Critical Care Medicine (553)
    • Medical Education (192)
    • Medical Ethics (51)
    • Nephrology (214)
    • Neurology (1691)
    • Nursing (97)
    • Nutrition (252)
    • Obstetrics and Gynecology (328)
    • Occupational and Environmental Health (451)
    • Oncology (930)
    • Ophthalmology (264)
    • Orthopedics (102)
    • Otolaryngology (172)
    • Pain Medicine (114)
    • Palliative Medicine (40)
    • Pathology (254)
    • Pediatrics (538)
    • Pharmacology and Therapeutics (255)
    • Primary Care Research (209)
    • Psychiatry and Clinical Psychology (1782)
    • Public and Global Health (3863)
    • Radiology and Imaging (626)
    • Rehabilitation Medicine and Physical Therapy (322)
    • Respiratory Medicine (522)
    • Rheumatology (208)
    • Sexual and Reproductive Health (170)
    • Sports Medicine (158)
    • Surgery (191)
    • Toxicology (36)
    • Transplantation (101)
    • Urology (76)